Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,290 | 1,998 | 2,429 | 2,582 | 2,822 |
| Cost of Goods | 1,367 | 3,272 | 943 | 1,183 | 1,555 |
| Gross Profit | 1,923 | -1,274 | 1,486 | 1,399 | 1,267 |
| Operating Expenses | 35,357 | 27,294 | 18,483 | 24,062 | 17,376 |
| Operating Income | -33,067 | -28,296 | -16,054 | -22,480 | -15,554 |
| Interest Expense | 0 | 0 | 0 | 0 | 301 |
| Other Income | 1,057 | 24 | -775 | 372 | 1,642 |
| Pre-tax Income | -32,010 | -28,272 | -16,829 | -22,108 | -14,213 |
| Net Income Continuous | -32,010 | -28,272 | -16,829 | -22,108 | -14,213 |
| Net Income | $-32,010 | $-28,272 | $-16,829 | $-22,108 | $-14,213 |
| EPS Basic Total Ops | -3.59 | -3.86 | -2.84 | 2,302.65 | -22.68 |
| EPS Basic Continuous Ops | -3.59 | -3.86 | -2.84 | 2,302.65 | -22.68 |
| EPS Diluted Total Ops | -3.59 | -3.86 | -2.84 | 2,302.65 | -22.68 |
| EPS Diluted Continuous Ops | -3.59 | -3.86 | -2.84 | 2,302.65 | -22.68 |
| EPS Diluted Before Non-Recurring Items | -3.59 | -3.86 | -2.84 | -9.77 | -23.00 |
| EBITDA(a) | $-32,606 | $-27,813 | $-15,496 | $-21,784 | $-14,835 |